Related Experiment Video
Updated: Jan 28, 2026

Multifocal Electroretinograms
Published on: December 4, 2011
The Incidence and Predisposing Factors of John Cunningham Virus-Induced Progressive Multifocal Leukoencephalopathy in
Marge Kartau1, Auli Verkkoniemi-Ahola1, Anders Paetau2
1Clinical Neurosciences, Neurology, Helsinki University Hospital and Helsinki University, Finland.
Background:
The aim of this study was to assess the prevalence, incidence rate (IR), predisposing factors, survival rate, and diagnostic delay of progressive multifocal leukoencephalopathy (PML) across medical specialties. Another objective was to survey how PML diagnosis was made in the studied cases.
Methods:
This is a cross-sectional retrospective observational study of PML cases across different medical specialties during 2004-2016 in the Finnish Capital Region and Southern Finland. Data were obtained from clinical records, clinical microbiology, pathology and radiology department records, and human immunodeficiency virus (HIV) quality register medical records.
Results:
A total of 31 patients were diagnosed with PML. The prevalence of PML was 1.56 per 100 000 people and the IR was 0.12 per 100 000 individuals per year during 2004-2016. Hematologic malignancies (n = 19) and HIV/acquired immune deficiency syndrome (n = 5) were the most common underlying diseases, and all patients who had malignant diseases had received cancer treatment. Before PML diagnosis, 21 (67.7%) patients were treated with chemotherapy, 14 (45.2%) patients with rituximab, and 1 patient (3.2%) with natalizumab. Two patients (6.5%) had no obvious immunocompromising disease or treatment. Neither gender, age, first symptoms, previous medication, nor underlying disease influenced the survival of PML patients significantly. The 5-year survival rate was poor, at less than 10%.
Conclusions:
The majority of PML patients in our study had a predisposing disease or had immunosuppressive or monoclonal antibody therapy. In the future, broader use of immunosuppressive and immunomodulatory medications may increase incidence of PML among patients with diseases unassociated with PML. Safety screening protocols for John Cunningham virus and PML are important to prevent new PML cases.
Insights
Progressive multifocal leukoencephalopathy (PML) affects 1.56 per 100,000 people, often linked to hematologic cancers or HIV. Survival rates are poor, highlighting the need for safety screening protocols.
Area of Science:
- Neurology
- Infectious Diseases
- Epidemiology
Background:
- Progressive multifocal leukoencephalopathy (PML) is a rare, serious demyelinating disease of the central nervous system.
- Assessing PML prevalence, incidence, and survival is crucial for understanding its impact across medical specialties.
Purpose of the Study:
- To determine the prevalence, incidence rate (IR), predisposing factors, survival rate, and diagnostic delay of PML.
- To investigate how PML diagnoses were made in various medical contexts.
Main Methods:
- A retrospective observational study was conducted from 2004-2016 in Finland.
- Data were collected from clinical records, laboratory, pathology, radiology, and HIV quality registers.
Main Results:
- 31 PML cases were identified, with a prevalence of 1.56/100,000 and an IR of 0.12/100,000 person-years.
- Hematologic malignancies (19 cases) and HIV/AIDS (5 cases) were most common; many patients received chemotherapy or rituximab.
- The 5-year survival rate was below 10%, with no significant impact from demographic or clinical factors on survival.
Conclusions:
- PML is frequently associated with predisposing conditions or immunosuppressive therapies.
- Increased use of immunomodulatory drugs may lead to more PML cases in unrelated diseases.
- Implementing safety screening for John Cunningham virus (JCV) is vital for preventing new PML cases.
More Related Videos
Related Concept Videos
Conservation of Small Populations
Southern Blot
Denatured DNA fragments must be transferred onto a carrier membrane from the gel to make it accessible to a probe - a small ssDNA fragment complementary to the target DNA...
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Population Growth
What is Population Genetics?
Transcription Factors

